These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30151947)

  • 1. Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.
    Cheraghlou S; Schettino A; Zogg CK; Otremba MD; Bhatia A; Park HS; Osborn HA; Mehra S; Yarbrough WG; Judson BL
    Laryngoscope; 2019 Apr; 129(4):883-889. PubMed ID: 30151947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
    Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemoradiotherapy versus with radiotherapy alone for locally advanced salivary gland carcinoma among older patients.
    Tanvetyanon T; Fisher K; Caudell J; Otto K; Padhya T; Trotti A
    Head Neck; 2016 Jun; 38(6):863-70. PubMed ID: 26340707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.
    Robin TP; Jones BL; Gordon OM; Phan A; Abbott D; McDermott JD; Goddard JA; Raben D; Lanning RM; Karam SD
    Cancer; 2017 Aug; 123(16):3040-3049. PubMed ID: 28369832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
    Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
    Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database.
    Cheraghlou S; Kuo P; Mehra S; Agogo GO; Bhatia A; Husain ZA; Yarbrough WG; Burtness BA; Judson BL
    Head Neck; 2018 Jul; 40(7):1343-1355. PubMed ID: 29756412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
    Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
    Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
    Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB
    BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-modality treatment in patients with advanced stage tonsil cancer.
    Roden DF; Schreiber D; Givi B
    Cancer; 2017 Sep; 123(17):3269-3276. PubMed ID: 28440876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma.
    Lee A; Givi B; Osborn VW; Schwartz D; Schreiber D
    Laryngoscope; 2017 Sep; 127(9):2057-2062. PubMed ID: 28194862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Salivary Cancer: Epidemiology, Treatment Trends, and Association of Treatment Modality with Survival.
    Morse E; Fujiwara RJT; Husain Z; Judson B; Mehra S
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):553-563. PubMed ID: 29688836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and outcome of patients with malignant salivary gland tumors.
    Bell RB; Dierks EJ; Homer L; Potter BE
    J Oral Maxillofac Surg; 2005 Jul; 63(7):917-28. PubMed ID: 16003616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
    Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
    Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
    Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
    Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
    Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
    Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of surgery and post-operative radiotherapy for major salivary gland carcinoma: ten year experience from a single institute.
    Kaur J; Goyal S; Muzumder S; Bhasker S; Mohanti BK; Rath GK
    Asian Pac J Cancer Prev; 2014; 15(19):8259-63. PubMed ID: 25339015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
    Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
    Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
    Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role of adjuvant treatment for salivary duct carcinoma?
    Nakashima T; Yasumatsu R; Toh S; Hashimoto K; Shinoto M; Nakamura K; Komune S
    J Laryngol Otol; 2015 Mar; 129 Suppl 2():S98-101. PubMed ID: 25706173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.